What is the normal starting dose of omeprazole (proton pump inhibitor) for a 1-month-old infant with impaired gastric function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Starting Dose of Omeprazole for a 1-Month-Old Infant

For a 1-month-old infant with impaired gastric function requiring omeprazole, the recommended starting dose is 0.7 mg/kg/day divided into two doses, which can be escalated up to 1.4-2.8 mg/kg/day based on clinical response. 1

Weight-Based Dosing Approach

  • The initial dose of 0.7 mg/kg/day should be divided into two daily doses (approximately 0.35 mg/kg twice daily) for severe or refractory GERD in infants under 2 years 1
  • Approximately 50% of infants require doses higher than the initial 0.7 mg/kg/day to achieve adequate acid control, necessitating dose titration based on clinical response 1
  • Doses may be escalated in increments of 0.7 mg/kg/day up to a maximum of 2.8 mg/kg/day in divided doses if initial dosing proves inadequate 1, 2

Practical Administration for a 1-Month-Old

  • Omeprazole should be compounded into a 6 mg/mL suspension by mixing capsule contents with applesauce or having a retail pharmacy prepare the suspension 1
  • For a typical 1-month-old infant weighing approximately 4 kg, the starting dose would be approximately 2.8 mg daily (0.7 mg/kg × 4 kg), which equals 0.47 mL of 6 mg/mL suspension divided into two doses 1
  • The suspension can be administered by mixing pellets from capsules with applesauce, ensuring pellets are not chewed or crushed 3

Critical Considerations for Neonates and Young Infants

  • Weight-based dosing recommendations for term infants should NOT be extrapolated to premature infants due to immature renal function and risk of drug accumulation 1
  • Infants have prolonged elimination half-lives (55-90 hours versus 30 hours in adults) and altered volumes of distribution, making weight-based approaches essential rather than extrapolating adult doses 1
  • Infants under 4 months demonstrate higher omeprazole levels and immature metabolism, with 17% being CYP2C19 poor metabolizers, suggesting the 0.5 mg/kg dose may be more appropriate to prevent accumulation 4

Dose Titration Algorithm

  1. Start with 0.7 mg/kg/day divided into two doses 1
  2. Reassess clinical response after 14 days with pH monitoring if available 2
  3. If inadequate response, increase by 0.7 mg/kg/day increments up to maximum 2.8 mg/kg/day 1, 2
  4. Monitor for clinical improvement including reduction in irritability, feeding difficulties, and vomiting 5

Important Caveats

  • FDA-approved dosing only exists for children ≥2 years of age (10 mg daily for weight 10-20 kg, 20 mg daily for weight ≥20 kg), making use in 1-month-old infants off-label 3
  • The majority of infants (50%) require dose escalation beyond the initial 0.7 mg/kg/day, so close monitoring and willingness to titrate upward is essential 1, 2
  • Research demonstrates that 20 mg/1.73 m² is inadequate for maintaining gastric pH >4 in infants, with 40 mg/1.73 m² being required for effective acid suppression 6
  • Long-term use beyond 2-3 months should prompt reassessment of the need for continued therapy 7

References

Guideline

Pediatric Omeprazole Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metabolism of omeprazole after two oral doses in children 1 to 9 months old.

Proceedings of the Western Pharmacology Society, 2005

Research

Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH.

Journal of pediatric gastroenterology and nutrition, 2001

Guideline

Omeprazole Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.